183 related articles for article (PubMed ID: 15961194)
1. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin.
Smallshaw JE; Richardson JA; Pincus S; Schindler J; Vitetta ES
Vaccine; 2005 Sep; 23(39):4775-84. PubMed ID: 15961194
[TBL] [Abstract][Full Text] [Related]
2. A pilot clinical trial of a recombinant ricin vaccine in normal humans.
Vitetta ES; Smallshaw JE; Coleman E; Jafri H; Foster C; Munford R; Schindler J
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2268-73. PubMed ID: 16461456
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72.
Kende M; Tan X; Wlazlowski C; Williams R; Lindsey C; Del Giudice G
Vaccine; 2007 Apr; 25(16):3219-27. PubMed ID: 17343960
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant.
Kende M; Del Giudice G; Rivera N; Hewetson J
Vaccine; 2006 Mar; 24(12):2213-21. PubMed ID: 16325310
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.
O'Hara JM; Brey RN; Mantis NJ
Clin Vaccine Immunol; 2013 Jun; 20(6):789-94. PubMed ID: 23515013
[TBL] [Abstract][Full Text] [Related]
6. Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection.
Roy CJ; Brey RN; Mantis NJ; Mapes K; Pop IV; Pop LM; Ruback S; Killeen SZ; Doyle-Meyers L; Vinet-Oliphant HS; Didier PJ; Vitetta ES
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3782-7. PubMed ID: 25775591
[TBL] [Abstract][Full Text] [Related]
7. The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage.
Baluna R; Coleman E; Jones C; Ghetie V; Vitetta ES
Exp Cell Res; 2000 Aug; 258(2):417-24. PubMed ID: 10896793
[TBL] [Abstract][Full Text] [Related]
8. RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.
Smallshaw JE; Richardson JA; Vitetta ES
Vaccine; 2007 Oct; 25(42):7459-69. PubMed ID: 17875350
[TBL] [Abstract][Full Text] [Related]
9. Progress in biological threat agent vaccine development: a repeat-dose toxicity study of a recombinant ricin toxin A-chain (rRTA) 1-33/44-198 vaccine (RVEc) in male and female New Zealand white rabbits.
McLain DE; Horn TL; Detrisac CJ; Lindsey CY; Smith LA
Int J Toxicol; 2011 Mar; 30(2):143-52. PubMed ID: 21378370
[TBL] [Abstract][Full Text] [Related]
10. Finding a new vaccine in the ricin protein fold.
Olson MA; Carra JH; Roxas-Duncan V; Wannemacher RW; Smith LA; Millard CB
Protein Eng Des Sel; 2004 Apr; 17(4):391-7. PubMed ID: 15187223
[TBL] [Abstract][Full Text] [Related]
11. Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen.
Thomas JC; O'Hara JM; Hu L; Gao FP; Joshi SB; Volkin DB; Brey RN; Fang J; Karanicolas J; Mantis NJ; Middaugh CR
Hum Vaccin Immunother; 2013 Apr; 9(4):744-52. PubMed ID: 23563512
[TBL] [Abstract][Full Text] [Related]
12. A novel recombinant vaccine which protects mice against ricin intoxication.
Smallshaw JE; Firan A; Fulmer JR; Ruback SL; Ghetie V; Vitetta ES
Vaccine; 2002 Sep; 20(27-28):3422-7. PubMed ID: 12213413
[TBL] [Abstract][Full Text] [Related]
13. Structure of RiVax: a recombinant ricin vaccine.
Legler PM; Brey RN; Smallshaw JE; Vitetta ES; Millard CB
Acta Crystallogr D Biol Crystallogr; 2011 Sep; 67(Pt 9):826-30. PubMed ID: 21904036
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of two recombinant ricin subunit vaccines in the New Zealand white rabbit subjected to a lethal aerosolized ricin challenge: survival, immunological response, and histopathological findings.
McLain DE; Lewis BS; Chapman JL; Wannemacher RW; Lindsey CY; Smith LA
Toxicol Sci; 2012 Mar; 126(1):72-83. PubMed ID: 21987460
[TBL] [Abstract][Full Text] [Related]
15. Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine.
Vitetta ES; Smallshaw JE; Schindler J
Clin Vaccine Immunol; 2012 Oct; 19(10):1697-9. PubMed ID: 22914366
[TBL] [Abstract][Full Text] [Related]
16. Process development and cGMP manufacturing of a recombinant ricin vaccine: an effective and stable recombinant ricin A-chain vaccine-RVEc™.
Meagher MM; Seravalli JG; Swanson ST; Ladd RG; Khasa YP; Inan M; Harner JC; Johnson SK; Van Cott K; Lindsey C; Wannemacher R; Smith LA
Biotechnol Prog; 2011 Jul; 27(4):1036-47. PubMed ID: 21630488
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin.
Neal LM; O'Hara J; Brey RN; Mantis NJ
Infect Immun; 2010 Jan; 78(1):552-61. PubMed ID: 19858297
[TBL] [Abstract][Full Text] [Related]
18. Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication.
Marconescu PS; Smallshaw JE; Pop LM; Ruback SL; Vitetta ES
Vaccine; 2010 Jul; 28(32):5315-22. PubMed ID: 20562013
[TBL] [Abstract][Full Text] [Related]
19. Strong protection against ricin challenge induced by a novel modified ricin A-chain protein in mouse model.
Zhang T; Yang H; Kang L; Gao S; Xin W; Yao W; Zhuang X; Ji B; Wang J
Hum Vaccin Immunother; 2015; 11(7):1779-87. PubMed ID: 26038805
[TBL] [Abstract][Full Text] [Related]
20. High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit Vaccine.
Toth RT; Angalakurthi SK; Van Slyke G; Vance DJ; Hickey JM; Joshi SB; Middaugh CR; Volkin DB; Weis DD; Mantis NJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
